Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 12/24/2012 1:28:10 PM : Outperform Start Price: $29.68 QCOR Score: -12.47

Fidelity total return by P/S. 1 of 4.

Featured Broker Partners


Advertisement